JPRN-jRCT2080221100未知2 期
A Phase II Additional Study of TAK-442 in patients with arterial thrombosis
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 30age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Patients aged 30-80 years (inclusive) with onset of arterial thrombosis
排除标准
- •1. Known hemorrhagic/coagulation disorder
- •2. Past or current history of intracranial hemorrhage.
- •3. Patients with a condition indicated for long-term anticoagulant therapy
- •4. Severe renal dysfunction or liver disorder
研究者
相似试验
未知
2 期
A phase II study of TAK-442 in patients with arterial thrombosisArterial thrombosisJPRN-jRCT2080220834Takeda Pharmaceutical Company Limited
招募中
不适用
An exploratory study of TAKC-02 in male patients with moderate bronchial asthmaD001249bronchial asthmaJPRN-jRCTs031220218Hida Noriko12
未知
1 期
A Phase I Multiple Administration Study of TAK-448 in Patients with Prostate CancerProstate CancerJPRN-jRCT2080220949Takeda Pharmaceutical Company Limited
未知
3 期
Phase III double-blind study of TAK-536CCB in patients with grade I or II essential hypertensioHypertensionJPRN-jRCT2080221566TAKEDA PHARMACEUTICAL COMPANY LTD.
未知
2 期
A Phase 2, Open-label, Single-arm Study of TAK-700 (orteronel) in Patients With Nonmetastatic Castration-resistant Prostate Cancer and Rising Prostate-specific AntigeJPRN-jRCT2080221969Takeda Pharmaceutical Company Limited30